台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    22.55
  • 漲跌
    ▲0.20
  • 漲幅
    +0.89%
  • 成交量
    320
  • 產業
    上市 生技醫療類股▲1.34%
  • 299人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
神隆 (1789)籌碼相關-元大-新營 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-新營 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/2300.00121.9022.00-1372-0.27%
2024/12/20121.8000.0021.6013730.27%
2024/12/13322.35222.2522.2013510.28%
2024/11/22323.45223.5023.5013720.27%
2024/11/06123.5000.0023.5513600.28%
2024/11/01223.30224.0524.2003950.00%
2024/10/29224.0000.0024.1023930.51%
2024/10/11224.8000.0024.6524810.42%
2024/09/04224.7000.0024.2528050.25%
2024/09/02125.4000.0025.3518160.12%
2024/08/2900.00125.3525.55-1854-0.12%
2024/08/2700.000.125.3025.30-0.1862-0.01%
2024/08/23125.2000.0025.3018790.11%
2024/08/0900.00125.0024.95-11,105-0.09%
2024/08/08224.550.224.8024.701.81,1060.17%
2024/08/0700.001025.0525.10-101,110-0.90%
2024/08/061023.7800.0024.35101,1140.90%
2024/08/05124.7000.0023.9511,1080.09%
2024/07/23226.5000.0026.4021,1770.17%
2024/07/19126.40126.3026.3501,1980.00%
2024/07/18126.8000.0026.8511,1880.08%
2024/07/09128.55128.4528.6501,2050.00%
2024/07/08229.08129.6029.0511,2200.08%
2024/07/04128.6000.0028.6011,2890.08%
2024/07/02129.0000.0028.8511,3320.08%
2024/07/01129.55229.7329.45-11,343-0.07%
2024/06/2800.00129.2029.00-11,329-0.08%
2024/06/2700.00228.9028.95-21,324-0.15%
2024/06/2600.00129.2029.10-11,371-0.07%
2024/06/2100.00128.5528.30-11,494-0.07%
2024/06/13128.3000.0028.3511,5420.06%
2024/06/1100.00129.3029.20-11,538-0.06%
2024/06/0600.000.228.5028.50-0.21,504-0.01%
2024/06/0500.00129.0028.90-11,512-0.07%
2024/06/040.328.9300.0028.900.31,5120.02%
2024/05/2800.00228.5028.50-21,491-0.13%
2024/05/22628.7800.0028.6561,4760.41%
2024/05/21530.15529.4029.3501,4530.00%
2024/05/1700.00428.5828.60-41,341-0.30%
2024/05/0800.00127.8527.90-11,299-0.08%
2024/05/07228.20328.9228.20-11,288-0.08%
2024/04/30128.8000.0028.7011,2510.08%
2024/04/29229.00329.0529.10-11,228-0.08%
2024/04/26128.10128.8028.1501,1760.00%
2024/04/190.127.50127.1026.75-0.91,147-0.08%
2024/04/11628.1000.0028.0561,0690.56%
2024/04/1000.00129.1028.70-11,040-0.10%
2024/04/08128.40128.4028.3009620.00%
2024/04/03427.10427.7027.7509190.00%
2024/03/2900.00527.9527.65-5876-0.57%
2024/03/281027.85727.8027.6538210.36%
2024/03/26126.2000.0026.0516890.15%
2024/03/2000.00326.3826.70-3661-0.45%
2024/03/1900.00125.7025.75-1606-0.16%
2024/03/18225.4500.0025.4026070.33%
2024/03/1500.00226.0026.10-2589-0.34%
2024/03/1300.00125.6525.65-1574-0.17%
2024/03/1100.00125.0025.35-1571-0.17%
2024/03/08424.5600.0024.5045600.71%
2024/02/2600.00125.2525.35-1604-0.17%
2024/02/1900.00125.6525.55-1614-0.16%
2024/02/1500.00125.2525.30-1620-0.16%
2024/02/0200.00225.4025.45-2630-0.32%
2024/02/01525.3500.0025.2556410.78%
2024/01/3100.00025.5025.1507010.00%
2024/01/1900.00125.4525.35-1792-0.13%
漢達私募引進神隆成第二大股東 攜手拓展改良型新藥Anue鉅亨-6天前
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
神隆 相關文章